Author

M. Stolovich-Rain

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Assay:proteomics· 3 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Research Focus:benchmarking· 1 Research Focus:protein folding & dynamics· 1 Approach:statistical model· 1 Organism:virus· 1

Frequent Co-Authors

A. Rouvinski· 3 shared L. Baraz· 3 shared A. Friedman· 2 shared D. G. Wolf· 2 shared D. Padawer· 2 shared E. Cohen-Kfir· 2 shared M. Billan· 2 shared M. Elgrably-Weiss· 2 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

A. Rouvinski

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Binding of SARS-CoV-2 nucleocapsid protein to uninfected epithelial cells induces antibody-mediated complement deposition

J. Fahoum, M. Billan, J. K. Varga, D. Padawer, M. Elgrably-Weiss, P. Basu, M. Stolovich-Rain, L. Baraz, S. Kumari, E. Oiknine-Dijan, M. Kumar, E. Cohen-Kfir, O. Zelig, G. Mayer, M. N. Isupov, , A. Rouvinski

This study shows that SARS-CoV-2 nucleocapsid protein binds to uninfected cells, triggering antibody-mediated complement activation in COVID-19 patients.

bioRxiv · Mar 17, 2024 · PreprintImmunology

Intramuscular mRNA BNT162b2 vaccine against SARS-CoV-2 induces robust neutralizing salivary IgA

M. Stolovich-Rain, S. Kumari, A. Friedman, S. Kirillov, Y. Socol, M. Billan, R. Ranjan Pal, P. Golding, E. Oiknine-Djian, S. Sirhan, M. Bejerano Sagie, E. Cohen-Kfir, M. Elgrably-Weiss, B. Zhou, M. Ravins, , A. Rouvinski

This study shows that the BNT162b2 mRNA vaccine induces temporary salivary IgA with strong neutralizing activity against SARS-CoV-2.

Frontiers in Immunology · Jan 30, 2023Peer-reviewedMicrobiology

Targeted in situ cross-linking mass spectrometry and integrative modeling reveal the architectures of Nsp1, Nsp2, and Nucleocapsid proteins from SARS-CoV-2

M. Slavin, J. Zamel, K. Zohar, S. Eliyahu, M. Braitbard, E. Brielle, L. Baraz, M. Stolovich-Rain, A. Friedman, D. G. Wolf, A. Rouvinski, M. Linial, D. Schneidman-Duhovny, N. Kalisman

This study uses targeted in situ CLMS and integrative modeling to determine the structures of SARS-CoV-2 Nsp1, Nsp2, and N proteins, revealing key interactions and functional insights.

bioRxiv · Feb 4, 2021Biochemistry